Nitric Oxide Versus Prostaglandin E1 for Reduction of Pulmonary Hypertension in Heart Transplant Candidates

2005 ◽  
Vol 24 (6) ◽  
pp. 690-695 ◽  
Author(s):  
Branislav Radovancevic ◽  
Bojan Vrtovec ◽  
Cynthia D. Thomas ◽  
Mihai Croitoru ◽  
Timothy J. Myers ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Pulmonary Hypertension ◽  
Heart Transplant ◽  
Prostaglandin E1 ◽  
Transplant Candidates

NITRIC OXIDE AND PROSTAGLANDIN El THERAPY FOR HEART TRANSPLANT CANDIDATES WITH SECONDARY PULMONARY HYPERTENSION.

2000 ◽  
Vol 69 (Supplement) ◽  
pp. S233
Author(s):  
Tehreen Khan ◽  
Branislav Radovancevic ◽  
Cynthia D. Thomas ◽  
Mihai Croitoru ◽  
Timothy J. Myers ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Pulmonary Hypertension ◽  
Heart Transplant ◽  
Secondary Pulmonary Hypertension ◽  
Transplant Candidates

scholarly journals Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates

2017 ◽  
Vol 10 (9) ◽  
Author(s):  
Stephen P. Wright ◽  
Yasbanoo Moayedi ◽  
Farid Foroutan ◽  
Suhail Agarwal ◽  
Geraldine Paradero ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Heart Transplant ◽  
Pressure Difference ◽  
Diastolic Pressure ◽  
Transplant Candidates

scholarly journals Update on the Use of Inhaled Nitric Oxide

1996 ◽  
Vol 3 (6) ◽  
pp. 373-376 ◽  
Author(s):  
Robert M Kacmarek
Keyword(s):  
Nitric Oxide ◽  
Pulmonary Hypertension ◽  
Inhaled Nitric Oxide ◽  
Pulmonary Vasculature ◽  
Vascular Effects ◽  
The Past ◽  
Chronic Pulmonary Hypertension ◽  
Transplant Candidates ◽  
Nitric Oxide Therapy ◽  
Rapid Binding

A literature review on nitric oxide would identify thousands of citations on the biological implications of this molecule. From the perspective of respiratory care, the effect inhaled nitric oxide has on pulmonary vasculature is the most intriguing. Over the past five years inhaled nitric oxide has been shown to be useful in the management of oxygenation during acute respiratory distress syndrome, alternation of pulmonary vascular tone in persistent pulmonary hypertension in the newborn, and in the management of chronic pulmonary hypertension in both heart and lung transplant candidates, as well as other potential clinical uses. The key physioligical response is vasodilation of pulmonary vessels in communication with well ventilated lung units and the absence of systemic vascular effects by rapid binding to hemoglobin. Nitric oxide therapy is considered experimental. A delivery system is not commercially available. This has resulted in the development of makeshift delivery systems, many of which may have the potential for adverse effects.

Effects of Nesiritide on Pulmonary Hypertension in Heart Transplant Candidates

2004 ◽  
Vol 10 (4) ◽  
pp. S23
Author(s):  
Reynolds M. Delgado ◽  
Branislav Radovancevic ◽  
Cynthia D. Thomas ◽  
Lisa A. Nemeth ◽  
Biswajit Kar ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Heart Transplant ◽  
Transplant Candidates
Sign in / Sign up

Export Citation Format

Share Document